Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework () Della-Torre E, Talarico R, Ballarin J, Bozzalla-Cassione E, Cardamone C, Cigolini C, Ferro F, et al. Journal article, Review article Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study (2025) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Düsing C, Krickau T, et al. Journal article First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study (2025) Kernder A, Filla T, Friedrich R, Blank N, Ernst D, Henes J, Keyßer G, et al. Journal article Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study (2025) Heß A, Tascilar K, Schenker H, Konerth L, Schönau V, Sergeeva M, Kreitz S, et al. Journal article From whole-brain metrics to circuitspecific precision: advancing fMRI biomarkers for TNF inhibitor response in rheumatoid arthritis – Authors' reply (2025) Heß A, Tascilar K, Schett G, Rech J Journal article Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study (2024) Borrego-Yaniz G, Ortiz-Fernández L, Madrid-Paredes A, Kerick M, Hernández-Rodríguez J, Mackie SL, Vaglio A, et al. Journal article Subclinical synovitis: let's discuss prognosis before treatment (2024) Yalcin-Mutlu M, Tascilar K Journal article CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article Prevention of seronegative rheumatoid arthritis: an entity of its own (2024) Bugatti S, Schett G Journal article Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial (2023) Venhoff N, Schmidt WA, Bergner R, Rech J, Unger L, Tony HP, Finzel S, et al. Journal article